Secondary Medical Use Part II: Developing Strategies for Enforcement
Guido Pontremoli
Corporate IP Patent Director
Chiesi Farmaceutici
Dr Philipp Cepl
Partner
DLA Piper
Nicolas Ruiz
Head of IP
Esteve
Arvid van Oorschot
Partner
Vondst Advocaten N.V.
- Understanding the scope of secondary medical use patents
- Enforcing a secondary medical use patent: a view from key stakeholders:
- Patentees
- Generic Pharmaceutical companies
- Biosimilar companies
- Discussing implications and consequences of failing to file a secondary medical use patent in time.